Literature DB >> 20333678

Norepinephrine antagonists and cancer risk.

Gary D Friedman, Natalia Udaltsova, Laurel A Habel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20333678      PMCID： PMC2993828          DOI： 10.1002/ijc.25351

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  4 in total

Review 1.  Is norepinephrine an etiological factor in some types of cancer?

Authors:  Paul J Fitzgerald
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

Review 2.  Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened.

Authors:  Gary D Friedman; Natalia Udaltsova; James Chan; Charles P Quesenberry; Laurel A Habel
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

3.  Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer.

Authors:  Paul J Fitzgerald
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

Review 4.  Hypertension, anti-hypertensive therapy and neoplasia.

Authors:  Patrick K Y Goon; Paul S Stonelake; Gregory Y H Lip
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116
  4 in total
  10 in total

Review 1.  Sympathetic nervous system regulation of the tumour microenvironment.

Authors:  Steven W Cole; Archana S Nagaraja; Susan K Lutgendorf; Paige A Green; Anil K Sood
Journal:  Nat Rev Cancer       Date:  2015-09       Impact factor: 60.716

2.  A pilot study of blood epinephrine levels and CREB phosphorylation in men undergoing prostate biopsies.

Authors:  Sazzad Hassan; Yelena Karpova; Anabel Flores; Ralph D'Agostino; Suzanne C Danhauer; Ashok Hemal; George Kulik
Journal:  Int Urol Nephrol       Date:  2013-09-21       Impact factor: 2.370

3.  Haloperidol and Prostate Cancer Prevention: More Epidemiologic Research Needed.

Authors:  Gary D Friedman; Laurel A Habel; Ninah Achacoso; Christina M Sanders; Halley M Oyer; Bruce Fireman; Stephen K Van Den Eeden; Felix J Kim
Journal:  Perm J       Date:  2019-11-22

4.  Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint.

Authors:  Paul J Fitzgerald
Journal:  Clin Epidemiol       Date:  2012-06-29       Impact factor: 4.790

5.  Can analyses of electronic patient records be independently and externally validated? Study 2--the effect of β-adrenoceptor blocker therapy on cancer survival: a retrospective cohort study.

Authors:  David A Springate; Darren M Ashcroft; Evangelos Kontopantelis; Tim Doran; Ronan Ryan; David Reeves
Journal:  BMJ Open       Date:  2015-04-13       Impact factor: 2.692

6.  A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients.

Authors:  Juergen Drewe; Kathleen A Bucher; Catherine Zahner
Journal:  Springerplus       Date:  2015-02-10

7.  Effects of Antihypertensive Drugs Use on Risk and Prognosis of Colorectal Cancer: A Meta-Analysis of 37 Observational Studies.

Authors:  Yujiao Deng; Yuxiu Xie; Meng Wang; Peng Xu; Bajin Wei; Na Li; Ying Wu; Si Yang; Linghui Zhou; Qian Hao; Lijuan Lyu; Dai Zhang; Zhijun Dai
Journal:  Front Pharmacol       Date:  2022-01-11       Impact factor: 5.810

8.  The Effects of Isoproterenol and Propranolol on Cytokine Profile Secretion by Cultured Tumor-infiltrating Lymphocytes Derived from Colorectal Cancer Patients.

Authors:  Shahram Seyedi; Alireza Andalib; Abbas Rezaei; Seyed Mohsen Hosseini; Seyed Reza Mohebbi; Mohammad Reza Zali; Mohamad Vafai; Roubik Behboo; Seyed Abbas Tabatabaei; Shahram Shahabi
Journal:  Cell J       Date:  2011-12-22       Impact factor: 2.479

9.  Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model.

Authors:  Guo-Hua Deng; Jie Liu; Jie Zhang; Ying Wang; Xing-Chen Peng; Yu-Quan Wei; Yu Jiang
Journal:  J Exp Clin Cancer Res       Date:  2014-02-20

10.  Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan.

Authors:  Shian-Ying Sung; Trang Thi Huynh Le; Jin-Hua Chen; Teng-Fu Hsieh; Chia-Ling Hsieh
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.